About Panalgo
Panalgo is a Healthcare company based in Boston (United States) founded in 1996, and was acquired by MMIT Network in September 2021. Provider of healthcare analytics software for clinics. Panalgo has raised $78 million across 1 funding round from investors including MMIT Network, Evaluate and Silversmith. Panalgo offers products and services including IHD Analytics, IHD Cloud, and NorstellaLinQ. Its focus areas include HealthTech, Life Sciences Tech, Data Analysis Platforms and Life Sciences. Its legal entity is Panalgo, LLC. Its competitors include Komodo Health, Elucidata and NyquistAI; 3 of its 3 listed competitors have raised funding.
Company details
Panalgo was founded in 1996 in Boston, United States, operating in the healthcare analytics sector. Software solutions are delivered to clinics for evaluating patient care quality and value. Codes are generated to help life science firms assess product worth. Research is designed and executed to measure medical technology impacts. Analytics are streamlined to support decision-making among pharma, payers, and providers.
- Headquarters Boston, United States
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website panalgo.com
- Social LinkedIn X
- Acquired by MMIT Network (Sep 2021)
- Legal Name Panalgo, Llc
- Total Equity Funding$78M (USD)
in 1 rounds
- Latest Funding Round$78M (USD), Series C
May 2019
- InvestorsMMIT Network
& 3 more
- Acquired byMMIT Network
(Sep 2021)
Products & Services of Panalgo
Panalgo offers a comprehensive portfolio of products and services, including IHD Analytics, IHD Cloud, and NorstellaLinQ.
Self-service platform for real-world evidence analysis and reporting.
Solution for centralizing RWE data and analytics efficiently.
Integrated data source for biopharma drug development insights.
Funding Insights of Panalgo
Panalgo has successfully raised a total of $78M through 1 strategic funding round. The most recent funding activity was a Series C round of $78 million completed in May 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $78M
- Total Rounds 1
- Last Round Series C — $78M
- First Round $78M
(May 2019)
- Investors Count 2
All 1 funding rounds of Panalgo with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2019 | $78M | Series C | – | Silversmith, Transformation Capital | – |
4 investors in total: 4 institutional.
Investors in Panalgo
Panalgo has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include MMIT Network, Evaluate and Silversmith.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm investing in technology and healthcare sectors | silversmith.com | Boston, United States | ||
Healthcare startups are funded by this venture capital firm. | transformcap.com | Boston, United States | ||
Pharmaceutical market intelligence and forecasting solutions are provided by Evaluate. | 1996 | evaluate.com | London, United Kingdom | |
Offers formulary data & analytics for market research, medication decision & formulary management | 1994 | mmitnetwork.com | Yardley, United States |
Investor details for Panalgo
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Panalgo
3 dated milestones of Panalgo across 25 years, from founding to its latest funding, stage changes and deals.
- Founded Panalgo is founded.
- Funding First funding round of $78.0M.
- Exit Acquired by MMIT Network.
Competitors of Panalgo
Panalgo has 3 listed competitors in our database, 3 of them funded. They include Komodo Health, Elucidata and NyquistAI.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| komodohealth.com | 2014 | New York, United States | $514M | 269 | Data-driven insights are delivered to healthcare via AI platforms. | |
| elucidata.io | 2015 | San Francisco, United States | $22.7M | 136 | Elucidata is focused on AI-powered biomedical data solutions for drug discovery and precision medicine. | |
| nyquistai.com | 2020 | Palo Alto, United States | $6M | Provider of cloud-based AI solution for the life sciences industry |
Detailed competitors of Panalgo
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Panalgo
The website of Panalgo (panalgo.com) receives about 4.2K visits a month and ranks #4,337,873 among all websites worldwide, #5,313 in Biotechnology and Pharmaceuticals.
- Monthly visits4.2K
▲ 0.9% vs previous month
- Unique visitors1.8K
per month
- Global rank#4,337,873
among all websites
- Category rank#5,313
Health · Biotechnology and Pharmaceuticals
- Bounce rate45%
- Pages per visit1.7
- Average visit34 sec
- DevicesDesktop 39% · Mobile 61%
Websites whose visitors overlap most with Panalgo. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
npcnow.org | npcnow.org | 100% | #3,198,114 | – | |
bettercareplaybook.org | bettercareplaybook.org | 97% | – | ||
themedicalcareblog.com | themedicalcareblog.com | 94% | #2,422,740 | – | |
healthcareitnews.com | healthcareitnews.com | 60% | #409,888 | – |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Panalgo (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Panalgo
Complete news archive for Panalgo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Panalgo
Panalgo was founded in 1996 and raised its 1st funding round 23 years after it was founded.
Panalgo is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Panalgo is a funded company, having raised a total of $78M across 1 funding round to date. The company's 1st funding round was a Series C of $78M, raised on May 2019.
Panalgo was founded in 1996 in Boston, United States, operating in the healthcare analytics sector. Software solutions are delivered to clinics for evaluating patient care quality and value. Codes are generated to help life science firms assess product worth. Research is designed and executed to measure medical technology impacts. Analytics are streamlined to support decision-making among pharma, payers, and providers.
Panalgo's top competitors include Komodo Health, Elucidata and NyquistAI.
Panalgo offers IHD Analytics, IHD Cloud, and NorstellaLinQ.
Panalgo has 4 investors. Key investors include MMIT Network, Evaluate, Silversmith, and Transformation Capital.
Panalgo operates through Panalgo, Llc.
Yes. Panalgo was acquired by MMIT Network in September 2021.